90 related articles for article (PubMed ID: 27323337)
1. Ranolazine improves insulin resistance in non-diabetic patients with coronary heart disease. A pilot study.
Caminiti G; Fossati C; Battaglia D; Massaro R; Rosano G; Volterrani M
Int J Cardiol; 2016 Sep; 219():127-9. PubMed ID: 27323337
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s).
El-Mesallamy HO; Hamdy NM; Salman TM; Mahmoud S
Minerva Endocrinol; 2011 Sep; 36(3):163-70. PubMed ID: 22019747
[TBL] [Abstract][Full Text] [Related]
3. Impact of ranolazine on coronary microvascular dysfunction (MICRO) study.
Ahmed B; Mondragon J; Sheldon M; Clegg S
Cardiovasc Revasc Med; 2017 Sep; 18(6):431-435. PubMed ID: 28576663
[TBL] [Abstract][Full Text] [Related]
4. Fasting hyperinsulinaemia and 2-h glycaemia predict coronary heart disease in patients with type 2 diabetes.
Faghihi-Kashani S; Bonnet F; Hafezi-Nejad N; Heidari B; Aghajani Nargesi A; Sheikhbahaei S; Ebadi M; Esteghamati A
Diabetes Metab; 2016 Feb; 42(1):55-61. PubMed ID: 26531321
[TBL] [Abstract][Full Text] [Related]
5. Factors related to exercise capacity in asymptomatic middle-aged type 2 diabetic patients.
Ugur-Altun B; Altun A; Tatli E; Tugrul A
Diabetes Res Clin Pract; 2005 Feb; 67(2):130-6. PubMed ID: 15649572
[TBL] [Abstract][Full Text] [Related]
6. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
7. A study of the effects of ranolazine using automated quantitative analysis of serial myocardial perfusion images.
Venkataraman R; Belardinelli L; Blackburn B; Heo J; Iskandrian AE
JACC Cardiovasc Imaging; 2009 Nov; 2(11):1301-9. PubMed ID: 19909934
[TBL] [Abstract][Full Text] [Related]
8. [Effect of panax quinquefolius saponin on insulin sensitivity in patients of coronary heart disease with blood glucose abnormality].
Zhang Y; Lu S; Liu YY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Dec; 27(12):1066-9. PubMed ID: 18198636
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients.
Yang Y; Wei RB; Xing Y; Tang L; Zheng XY; Wang ZC; Gao YW; Li MX; Chen XM
Metabolism; 2013 Dec; 62(12):1858-66. PubMed ID: 24050270
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance and acute coronary syndrome.
Caccamo G; Bonura F; Bonura F; Vitale G; Novo G; Evola S; Evola G; Grisanti MR; Novo S
Atherosclerosis; 2010 Aug; 211(2):672-5. PubMed ID: 20466373
[TBL] [Abstract][Full Text] [Related]
11. Comparative Effectiveness of Ranolazine Versus Traditional Therapies in Chronic Stable Angina Pectoris and Concomitant Diabetes Mellitus and Impact on Health Care Resource Utilization and Cardiac Interventions.
Page RL; Ghushchyan V; Read RA; Hartsfield CL; Koch BR; Nair KV
Am J Cardiol; 2015 Nov; 116(9):1321-8. PubMed ID: 26358510
[TBL] [Abstract][Full Text] [Related]
12. Retinol-binding protein 4 (RBP-4) levels do not change after oral glucose tolerance test and after dexamethasone, but correlate with some indices of insulin resistance in humans.
Lewandowski KC; Basinska-Lewandowska M; Bieńkiewicz M; Randeva HS; Lewiński A
Endokrynol Pol; 2008; 59(4):305-11. PubMed ID: 18777500
[TBL] [Abstract][Full Text] [Related]
13. The relationship between insulin resistance and cardiovascular risk factors in overweight/obese non-diabetic Asian adults: the 1992 Singapore National Health Survey.
Lim SC; Tan BY; Chew SK; Tan CE
Int J Obes Relat Metab Disord; 2002 Nov; 26(11):1511-6. PubMed ID: 12439654
[TBL] [Abstract][Full Text] [Related]
14. [Effects of a superselective beta1-adrenoblocker nebivolol on the course of coronary heart disease and insulin resistance in patients with diabetes mellitus type 2 after coronary artery bypass grafting].
Tepliakov AT; Kuznetsova AV; Lukinov AV; Levshin AV
Ter Arkh; 2007; 79(12):38-43. PubMed ID: 18220029
[TBL] [Abstract][Full Text] [Related]
15. Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial.
Alexander KP; Weisz G; Prather K; James S; Mark DB; Anstrom KJ; Davidson-Ray L; Witkowski A; Mulkay AJ; Osmukhina A; Farzaneh-Far R; Ben-Yehuda O; Stone GW; Ohman EM
Circulation; 2016 Jan; 133(1):39-47. PubMed ID: 26555329
[TBL] [Abstract][Full Text] [Related]
16. Association of the + 45T>G adiponectin gene polymorphism with insulin resistance in non-diabetic Saudi women.
Mackawy AM
Gene; 2013 Nov; 530(1):158-63. PubMed ID: 23958652
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with insulin resistance and fasting plasma ghrelin levels in adolescents with obesity and family history of type 2 diabetes.
Liu BW; Lu Q; Ma CM; Wang SY; Lou DH; Lou XL; Yin FZ
Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):600-4. PubMed ID: 19618346
[TBL] [Abstract][Full Text] [Related]
18. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.
Weisz G; Généreux P; Iñiguez A; Zurakowski A; Shechter M; Alexander KP; Dressler O; Osmukhina A; James S; Ohman EM; Ben-Yehuda O; Farzaneh-Far R; Stone GW;
Lancet; 2016 Jan; 387(10014):136-45. PubMed ID: 26474810
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
Amoah AG; Schuster DP; Gaillard T; Osei K
Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
[TBL] [Abstract][Full Text] [Related]
20. Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
Melloni C; Newby LK
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):9-16. PubMed ID: 18095903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
